LEADER 02056nam  2200373   450 
001 9910688456303321
005 20230703113503.0
024 7 $a10.5772/intechopen.77767
035   $a(CKB)5400000000045337
035   $a(NjHacI)995400000000045337
035   $a(EXLCZ)995400000000045337
100   $a20230703d2019      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGastritis $eNew Approaches and Treatments /$fBruna Maria Roesler, editor
210  1$aLondon :$cIntechOpen,$d2019.
215   $a1 online resource (128 pages)
311   $a1-83968-009-1 
320   $aIncludes bibliographical references.
330   $aThe isolation and identification of Helicobacter pylori as the cause of gastrointestinal diseases had major implications for public health and led to curative treatments that reduced suffering from many acute and chronic conditions. Although alternative therapies have been used to improve eradication, current treatments still rely on a combination of antimicrobial agents often associated with antisecretory agents, such as proton pump inhibitors. In this book there is a comprehensive overview by contributors on H. pylori infection in diverse areas, including a general overview of H. pylori infection, and discussions about the principal therapeutic regimens of bacterium eradication, considering antimicrobial resistance. Also, certain aspects of autoimmune gastritis, an important condition that has been related to microorganism infection, is also considered. H. pylori is clearly a very interesting bacterium and great studies and discussions about all its aspects are welcomed by the medical and scientific communities.
517   $aGastritis 
606   $aEndocrinology
615  0$aEndocrinology.
676   $a616.4
702   $aRoesler$b Bruna Maria
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688456303321
996   $aGastritis$92953919
997   $aUNINA